EP4682140A1 — Improved process for the preparation of olaparib
Assigned to Fabbrica Italiana Sintetici SpA (FIS) · Expires 2026-01-21 · 0y expired
What this patent protects
Object of the present invention is an improved process for the preparation of Olaparib of formula (9): comprising the step of hydrolysis of intermediate of formula (11): with a strong acid to give compound of formula (5): which is then converted to Olaparib of f…
USPTO Abstract
Object of the present invention is an improved process for the preparation of Olaparib of formula (9): comprising the step of hydrolysis of intermediate of formula (11): with a strong acid to give compound of formula (5): which is then converted to Olaparib of formula (9).
Drugs covered by this patent
- Lynparza (olaparib) · AstraZeneca
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.